Skip to main content
رجوع
ALHC logo

Alignment Healthcare, Inc.

جودة البيانات: 100%
ALHC
NASDAQ Healthcare Medical - Healthcare Plans
KWD 17.51
▲ KWD 0.17 (0.98%)
القيمة السوقية: 3.58B
نطاق اليوم
KWD 17.07 KWD 17.81
نطاق 52 أسبوعًا
KWD 11.63 KWD 23.87
حجم التداول
3,428,907
متوسط 50 يوم / 200 يوم
KWD 20.42 / KWD 17.32
الإغلاق السابق
KWD 17.34

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -4940.9 0.4
P/B 20.0 2.9
ROE % -0.5 3.8
Net Margin % 0.0 3.9
Rev Growth 5Y % 35.6 10.0
D/E 1.9 0.2

السعر المستهدف للمحللين

Hold
KWD 24.500 +39.9%
Low: KWD 18.000 High: KWD 30.000
مكرر الربحية المستقبلي
133.2
ربحية السهم المستقبلية
KWD 0.132
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
5.2 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 1.710
KWD 1.638 – KWD 1.799
14 B 1
FY2029 KWD 1.290
KWD 1.235 – KWD 1.357
11 B 1
FY2028 KWD 0.726
KWD 0.523 – KWD 0.863
8 B 5

النقاط الرئيسية

Revenue grew 35.60% annually over 5 years — strong growth
Generating 113.15M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10.46%
Capital efficient — spends only 0.68% of revenue on capex
ROIC of 2.14% — low return on invested capital
Interest coverage of 0.93× — tight debt servicing

النمو

Revenue Growth (5Y)
35.60%
Revenue (1Y)46.06%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-0.52%
ROIC2.14%
Net Margin-0.02%
Op. Margin0.37%

الأمان

Debt / Equity
1.89
Current Ratio1.74
Interest Coverage0.93

التقييم

P/E Ratio
-4940.93
P/B Ratio19.95
EV/EBITDA226.23
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 46.06% Revenue Growth (3Y) 47.15%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 35.60% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3.95B Net Income (TTM) -724,000.0
ROE -0.52% ROA -0.07%
Gross Margin 12.37% Operating Margin 0.37%
Net Margin -0.02% Free Cash Flow (TTM) 113.15M
ROIC 2.14% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.89 Current Ratio 1.74
Interest Coverage 0.93 Dividend Yield 0.00%
Valuation
P/E Ratio -4940.93 P/B Ratio 19.95
P/S Ratio 0.91 PEG Ratio 54.31
EV/EBITDA 226.23 Dividend Yield 0.00%
Market Cap 3.58B Enterprise Value 3.34B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3.95B 2.70B 1.82B 1.43B 1.17B
Net Income -724,000.0 -128.04M -148.02M -149.55M -195.29M
EPS (Diluted) 0.00 -0.67 -0.79 -0.83 -1.14
Gross Profit 488.56M 296.69M 201.03M 184.28M 128.73M
Operating Income 14.75M -101.56M -127.82M -128.64M -178.07M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.07B 782.06M 591.88M 633.86M 630.90M
Total Liabilities 886.51M 681.11M 433.81M 394.56M 324.84M
Shareholders' Equity 179.28M 99.85M 156.95M 238.13M 306.04M
Total Debt 338.07M 329.26M 170.79M 164.60M 157.60M
Cash & Equivalents 577.94M 432.86M 202.90M 409.55M 466.60M
Current Assets 831.14M 661.64M 483.54M 544.55M 552.86M
Current Liabilities 476.53M 351.85M 263.02M 229.96M 167.25M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#104 of 616
67

النشاط الأخير

دخل Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026